Literature DB >> 21076561

Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa.

Ilona Carneiro1, Lucy Smith, Amanda Ross, Arantxa Roca-Feltrer, Brian Greenwood, Joanna Armstrong Schellenberg, Thomas Smith, David Schellenberg.   

Abstract

OBJECTIVE: To develop a decision-support tool to help policy-makers in sub-Saharan Africa assess whether intermittent preventive treatment in infants (IPTi) would be effective for local malaria control.
METHODS: An algorithm for predicting the effect of IPTi was developed using two approaches. First, study data on the age patterns of clinical cases of Plasmodium falciparum malaria, hospital admissions for infection with malaria parasites and malaria-associated death for different levels of malaria transmission intensity and seasonality were used to estimate the percentage of cases of these outcomes that would occur in children aged <10 years targeted by IPTi. Second, a previously developed stochastic mathematical model of IPTi was used to predict the number of cases likely to be averted by implementing IPTi under different epidemiological conditions. The decision-support tool uses the data from these two approaches that are most relevant to the context specified by the user.
FINDINGS: Findings from the two approaches indicated that the percentage of cases targeted by IPTi increases with the severity of the malaria outcome and with transmission intensity. The decision-support tool, available on the Internet, provides estimates of the percentage of malaria-associated deaths, hospitalizations and clinical cases that will be targeted by IPTi in a specified context and of the number of these outcomes that could be averted.
CONCLUSION: The effectiveness of IPTi varies with malaria transmission intensity and seasonality. Deciding where to implement IPTi must take into account the local epidemiology of malaria. The Internet-based decision-support tool described here predicts the likely effectiveness of IPTi under a wide range of epidemiological conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076561      PMCID: PMC2971505          DOI: 10.2471/BLT.09.072397

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  43 in total

1.  Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview.

Authors:  Thomas Smith; Gerry F Killeen; Nicolas Maire; Amanda Ross; Louis Molineaux; Fabrizio Tediosi; Guy Hutton; Jürg Utzinger; Klaus Dietz; Marcel Tanner
Journal:  Am J Trop Med Hyg       Date:  2006-08       Impact factor: 2.345

2.  Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.

Authors:  Eusebio Macete; Pedro Aide; John J Aponte; Sergi Sanz; Inacio Mandomando; Mateu Espasa; Betuel Sigauque; Carlota Dobaño; Samuel Mabunda; Martinho DgeDge; Pedro Alonso; Clara Menendez
Journal:  J Infect Dis       Date:  2006-06-30       Impact factor: 5.226

3.  Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

Authors:  D Schellenberg; C Menendez; E Kahigwa; J Aponte; J Vidal; M Tanner; H Mshinda; P Alonso
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

4.  Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa.

Authors:  J C Beier; G F Killeen; J I Githure
Journal:  Am J Trop Med Hyg       Date:  1999-07       Impact factor: 2.345

5.  Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.

Authors:  Daniel Chandramohan; Seth Owusu-Agyei; Ilona Carneiro; Timothy Awine; Kwame Amponsa-Achiano; Nathan Mensah; Shabbar Jaffar; Rita Baiden; Abraham Hodgson; Fred Binka; Brian Greenwood
Journal:  BMJ       Date:  2005-10-01

6.  Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.

Authors:  Roly D Gosling; Samwel Gesase; Jacklin F Mosha; Ilona Carneiro; Ramadhan Hashim; Martha Lemnge; Frank W Mosha; Brian Greenwood; Daniel Chandramohan
Journal:  Lancet       Date:  2009-09-16       Impact factor: 79.321

7.  A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.

Authors:  Robin Kobbe; Christina Kreuzberg; Samuel Adjei; Benedicta Thompson; Iris Langefeld; Peter Apia Thompson; Harry Hoffman Abruquah; Benno Kreuels; Matilda Ayim; Wibke Busch; Florian Marks; Kwado Amoah; Ernest Opoku; Christian G Meyer; Ohene Adjei; Jürgen May
Journal:  Clin Infect Dis       Date:  2007-05-29       Impact factor: 9.079

8.  Comparison of two strategies for control of malaria within a primary health care programme in the Gambia.

Authors:  B M Greenwood; A M Greenwood; A K Bradley; R W Snow; P Byass; R J Hayes; A B N'Jie
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

9.  Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana.

Authors:  Matthew Cairns; Ilona Carneiro; Paul Milligan; Seth Owusu-Agyei; Timothy Awine; Roly Gosling; Brian Greenwood; Daniel Chandramohan
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

10.  Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali.

Authors:  Alassane Dicko; Issaka Sagara; Mahamadou S Sissoko; Ousmane Guindo; Abdoulbaki I Diallo; Mamady Kone; Ousmane B Toure; Massambou Sacko; Ogobara K Doumbo
Journal:  Malar J       Date:  2008-07-08       Impact factor: 2.979

View more
  9 in total

1.  Functional Analysis Reveals Geographical Variation in Inhibitory Immune Responses Against a Polymorphic Malaria Antigen.

Authors:  Amy K Bei; Ambroise D Ahouidi; Jeffrey D Dvorin; Kazutoyo Miura; Ababacar Diouf; Daouda Ndiaye; Zul Premji; Mahamadou Diakite; Souleymane Mboup; Carole A Long; Manoj T Duraisingh
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

2.  The epidemiological impact of HIV antiretroviral therapy on malaria in children.

Authors:  Scott Greenhalgh; Martial Ndeffo; Alison P Galvani; Sunil Parikh
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.177

3.  The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings.

Authors:  Arantxa Roca-Feltrer; Ilona Carneiro; Lucy Smith; Joanna Rm Armstrong Schellenberg; Brian Greenwood; David Schellenberg
Journal:  Malar J       Date:  2010-10-13       Impact factor: 2.979

4.  Modelling malaria elimination on the internet.

Authors:  Richard J Maude; Sompob Saralamba; Adrian Lewis; Dean Sherwood; Nicholas J White; Nicholas P J Day; Arjen M Dondorp; Lisa J White
Journal:  Malar J       Date:  2011-07-14       Impact factor: 2.979

Review 5.  Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies.

Authors:  Cho Naing; Vanessa Racloz; Maxine Anne Whittaker; Kyan Aung; Simon Andrew Reid; Joon Wah Mak; Marcel Tanner
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

6.  Exploring the impact of targeted distribution of free bed nets on households bed net ownership, socio-economic disparities and childhood malaria infection rates: analysis of national malaria survey data from three sub-Saharan Africa countries.

Authors:  Joseph D Njau; Rob Stephenson; Manoj Menon; S Patrick Kachur; Deborah A McFarland
Journal:  Malar J       Date:  2013-07-15       Impact factor: 2.979

Review 7.  A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria.

Authors:  Cho Naing; Maxine A Whittaker; Joon Wah Mak; Kyan Aung
Journal:  Malar J       Date:  2015-10-06       Impact factor: 2.979

8.  Modeling the public health impact of malaria vaccines for developers and policymakers.

Authors:  Julia K Nunes; Vicky Cárdenas; Christian Loucq; Nicolas Maire; Thomas Smith; Craig Shaffer; Kårstein Måseide; Alan Brooks
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

9.  Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa.

Authors:  Jamie T Griffin; Neil M Ferguson; Azra C Ghani
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.